Hair / health / critical readingA thread between questions and evidence
Calvizie / CapelliThe thread of evidence
The journal / guide

Alopecia areata: different from pattern hair loss

Alopecia areata is an autoimmune, non-scarring condition. Its course varies: the possibility of regrowth does not allow anyone to promise a result or predict further episodes.

Updated 15 October 2026Editorial source check · no individual clinical review claimed
A wave of chestnut hair with copper highlights on ivory paper.
Material, light, movement.AI-generated editorial photograph · no clinical results

What the name describes

Alopecia means loss of hair. In alopecia areata, the immune system affects the follicle without the scarring destruction seen in some other conditions. The scalp, beard, eyebrows or other areas can be involved.

A patch alone does not identify the cause with certainty. Even when a photograph resembles an example in a guide, clinical assessment is needed. Not every localised area of hair loss is alopecia areata.

Be clear about uncertainty

Hair can regrow, but the course cannot be predicted precisely and further episodes are possible. Comparing your experience with an absolute online promise, whether positive or negative, is unlikely to help.

Treatment discussions depend on a clinician’s assessment. Treatments for androgenetic thinning do not automatically suit an autoimmune condition. A list of medicines in an overseas source does not establish their availability, approved indications or reimbursement in Italy or your country.

What to ask during the appointment

  • Which findings confirm the diagnosis, and what remains uncertain?
  • Is further investigation needed, or is clinical assessment sufficient?
  • What are the goals and limitations of the options being considered?
  • How should follow-up and communication of changes be organised?

You can also ask about cosmetic coverage and emotional support. Distress is worth mentioning to your clinician. Decisions can take daily life into account as well as appearance, without assuming that everyone wants the same approach.

Web editorial team · 2026 edition

Original text prepared with automated writing assistance and reference checks. No individual clinical reviewer is attributed to this guide.

Methods, limitations and corrections ↗

Sources and limitations

  1. Alopecia areataBritish Association of Dermatologists · Document: 2024-04 · Editorial check: 15 October 2026Used for the definition and variable course. UK medicine lists, ages and reimbursement are not treated as current Italian information.
  2. Therapeutic innovation in trichology: JAK inhibitors and alopecia areataSIDeMaST · Document: 2024-07-22 · Editorial check: 15 October 2026An informational article, rather than a comprehensive guideline or current reimbursement list. SIDeMaST has not reviewed this website.
  3. Summary of product characteristics and patient information leafletAIFA · Document: date not stated · Editorial check: 15 October 2026A methodological page; it does not verify the current SmPC of every medicine.